Teladoc Health, Inc. (BMV:TDOC)
150.00
-12.00 (-7.41%)
At close: Oct 10, 2025
Teladoc Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
Net Income | -207.36 | -1,001 | -220.37 | -13,660 | -428.79 | -485.14 | Upgrade |
Depreciation & Amortization | 368.55 | 382.84 | 348.72 | 267.78 | 219.52 | 78.09 | Upgrade |
Stock-Based Compensation | 109.03 | 145.95 | 201.55 | 217.85 | 302.59 | 475.53 | Upgrade |
Other Adjustments | -24.07 | 802.45 | 8.48 | 13,412 | 144.56 | -31.51 | Upgrade |
Change in Receivables | -5.9 | -0.38 | -10.25 | -49.06 | -11.17 | -21.09 | Upgrade |
Changes in Inventories | -2.86 | -9.75 | 24.1 | 14.8 | -19.49 | -24.73 | Upgrade |
Changes in Accounts Payable | -3.7 | -10.37 | -4.19 | 1.88 | 1.19 | -88 | Upgrade |
Changes in Accrued Expenses | 40.63 | 9.68 | 28.25 | 48.93 | 13.5 | 54.94 | Upgrade |
Changes in Unearned Revenue | -22.69 | -18.25 | -4.9 | 15.24 | 20.55 | 17.75 | Upgrade |
Changes in Other Operating Activities | -7.33 | -7.26 | -21.36 | -80.17 | -48.56 | -29.36 | Upgrade |
Operating Cash Flow | 303.43 | 293.68 | 350.02 | 189.29 | 193.99 | -53.51 | Upgrade |
Operating Cash Flow Growth | -8.96% | -16.10% | 84.91% | -2.42% | - | - | Upgrade |
Capital Expenditures | -11.72 | -10.79 | -11.46 | -16.48 | -8.53 | -4.02 | Upgrade |
Purchases of Intangible Assets | -110.89 | -113.26 | -144.88 | -156.28 | -55.4 | -22.02 | Upgrade |
Proceeds from Sale of Investments | - | - | - | 2.51 | 60.9 | 2.5 | Upgrade |
Payments for Business Acquisitions | - | - | - | - | -78.66 | -567.43 | Upgrade |
Other Investing Activities | - | - | 0 | 2.51 | 8.72 | 0 | Upgrade |
Investing Cash Flow | -243.76 | -124.05 | -156.35 | -167.74 | -72.98 | -590.98 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 6 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -8.64 | Upgrade |
Net Short-Term Debt Issued (Repaid) | - | - | - | - | - | -2.63 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 1,000 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | - | -238.15 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | - | 761.85 | Upgrade |
Issuance of Common Stock | 4.3 | 8.31 | 11.13 | 12.39 | 42.59 | 59.04 | Upgrade |
Net Common Stock Issued (Repurchased) | 4.3 | 8.31 | 11.13 | 12.39 | 42.59 | 59.04 | Upgrade |
Other Financing Activities | - | -0 | -0.28 | -5.89 | -5.07 | 67.59 | Upgrade |
Financing Cash Flow | -546.41 | 8.31 | 10.85 | 6.5 | 40.95 | 859.14 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 3.97 | -3.29 | 0.97 | -3.34 | -1.8 | 4.32 | Upgrade |
Net Cash Flow | -486.74 | 177.94 | 204.53 | 28.05 | 161.96 | 214.65 | Upgrade |
Beginning Cash & Cash Equivalents | 1,162 | 1,124 | 918.18 | 893.48 | 733.32 | 514.35 | Upgrade |
Ending Cash & Cash Equivalents | 679.62 | 1,298 | 1,124 | 918.18 | 893.48 | 733.32 | Upgrade |
Free Cash Flow | 291.71 | 282.89 | 338.56 | 172.81 | 185.46 | -57.54 | Upgrade |
Free Cash Flow Growth | 3.12% | -16.44% | 95.91% | -6.82% | - | - | Upgrade |
FCF Margin | 11.47% | 11.01% | 13.01% | 7.18% | 9.12% | -5.26% | Upgrade |
Free Cash Flow Per Share | 1.68 | 1.66 | 2.06 | 1.07 | 1.18 | -0.64 | Upgrade |
Levered Free Cash Flow | 153.52 | -665.13 | 138.78 | -13,408 | -250.62 | 278.75 | Upgrade |
Unlevered Free Cash Flow | 122.05 | -692.57 | 109.74 | -13,397 | -117.94 | -421.87 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.